MoonLake Immunotherapeutics
MLTX
MLTX
42 hedge funds and large institutions have $109M invested in MoonLake Immunotherapeutics in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
42
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.59M | |
| 2 | +$613K | |
| 3 | +$259K | |
| 4 |
MWM
Meridian Wealth Management
Lexington,
Kentucky
|
+$193K |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$137K |
Top Sellers
| 1 | -$1.77M | |
| 2 | -$1.68M | |
| 3 | -$1.04M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$796K |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$565K |